This is quite significant, considering 61% of COVID-19 patients were seeking neuropathic pain treatments at the follow-up [ 23 ].
← all excerpts
COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis.
1
—
—
This is quite significant, considering 61% of COVID-19 patients were seeking neuropathic pain treatments at the follow-up [ 23 ].